GENEPHARM AMLODIPINE amlodipine 2.5 mg (as besilate) tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

amlodipine besilate, Quantity: 3.5 mg

Disponible depuis:

Arrotex Pharmaceuticals Pty Ltd

DCI (Dénomination commune internationale):

amlodipine besilate

forme pharmaceutique:

Tablet, uncoated

Composition:

Excipient Ingredients: lactose monohydrate; magnesium stearate; maize starch; microcrystalline cellulose

Mode d'administration:

Oral

Unités en paquet:

30 tablets

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Hypertension - Genepharm Amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. Patients not adequately controlled on a single antihypertensive agent may benefit from the addition of Genepharm Amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor. Angina - Genepharm Amlodipine is indicated for the first line treatment of chronic stable angina. Genepharm Amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.

Descriptif du produit:

Visual Identification: white to off white, round, unscored tablets, engraved "APO" on one side and "AML" over "2.5" on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2007-12-13